issued
on 28 Nov 2023
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
97690361 filed on 23rd Nov 2022
Registration Number
N/A
Correspondent Address
MARILYN F. KELLY
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use
No 97690361
No Service/Collective Mark
No 00161740-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
03rd Oct 2023 | PUBLISHED FOR OPPOSITION |
03rd Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
13th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
28th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
25th Aug 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
24th Aug 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
24th Aug 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
02th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |